WHO ICTRP trial

A Phase 3 Randomized, Double-Masked, Placebo-Controlled Study of the…

NL-OMON37657 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting

Key facts

Trial ID NL-OMON37657
Public title A Phase 3 Randomized, Double-Masked, Placebo-Controlled Study of the Pharmacokinetics of OMS302 and the Effect of OMS302 on Intraoperative Pupil Diameter and Early Postoperative Pain in Subjects Undergoing Intra Ocular Lens Replacement with Phacoemulsification.
Scientific title A Phase 3 Randomized, Double-Masked, Placebo-Controlled Study of the Pharmacokinetics of OMS302 and the Effect of OMS302 on Intraoperative Pupil Diameter and Early Postoperative Pain in Subjects Undergoing Intra Ocular Lens Replacement with Phacoemulsification. - ILR4
Primary sponsor Omeros Corporation
Registry Overview of Medical Research in the Netherlands (NL-OMON)
Recruitment status Not Recruiting
Study type Interventional
Phase 3
Countries Austria;Netherlands ;United States of America
Conditions Cataract Intra Ocular Lens Replacement with Phacoemulsification;10002693;10015957;Cataract;Intra Ocular Lens Replacement with Phacoemulsification
Interventions Standard intraocular surgical techniques for ILR will be used. For the purposes of this study, the following procedures are to be executed: 1. The surgeon will utilize the test irrigation solutions at all times during the operation. 2…
Registration date Jul 23, 2012
Target size 15
Secondary IDs 2012-000867-25;NL40276.075.12
Registry page onderzoekmetmensen.nl

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations